SAN ANTONIO — Several types of anti-obesity medications (AOMs), including glucagon-like peptide 1s (GLP-1s), are associated ...

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...

Hanmi Pharm. Co., Ltd. has announced promising research results for its novel obesity treatment, HM17321. This groundbreaking drug not only augments fat loss but also significantly increases lean ...

Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications.

The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...

Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories ...

New research suggests that Ozempic may be a helpful treatment for knee pain caused by osteoarthritis. Here’s what you need to know.

“There are genetic aspects, physical aspects, and inflammatory aspects,” he says. Ozempic can help people to lose weight, ...

The clinical-stage drugmaker is developing an anti-obesity drug that could go on to produce record-breaking sales. Viking's ...

BRUSSELS/LONDON (Reuters) -EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings' acquisition of ...

In the United States, where 12% of adults say that they have at some stage taken GLP-1 agonists for diabetes or weight loss ...